Pharmaceutical — active
Ozempic / GLP-1 Injury
Claims involving severe gastrointestinal injuries linked to Ozempic and similar GLP-1 drugs.
Symptoms & Injuries
- Gastroparesis
- Bowel obstruction
- Persistent vomiting
- Hospitalization
Eligibility Criteria
- Used Ozempic, Wegovy, or Mounjaro
- Severe GI injury requiring treatment
Hospitalization for gastroparesis, bowel obstruction, or related GI injury.
Timeline
1
Case Evaluation
Free review of your claim by participating attorneys.
2
Investigation
Gathering medical records, usage history, and damages documentation.
3
Filing / MDL
Claims may proceed individually or through consolidated MDL proceedings.
4
Discovery & Negotiation
Evidence exchange and potential settlement discussions.
MDL Information
GLP-1 RA MDL (MDL No. 3094) — In re: Glucagon-Like Peptide-1 Receptor Agonists Products Liability Litigation.
FAQ
Free Case Evaluation
See if you may qualify. No fees unless you win with a participating attorney.
Start Free ReviewLegal Disclaimer
- • ATTORNEY ADVERTISING. This website is a legal lead-generation platform and is not a law firm. No attorney-client relationship is formed by using this website or submitting a form. Past results do not guarantee future outcomes. Cases are reviewed by independent participating law firms. Submitting a form does not guarantee representation or compensation.
- • Submitting a form does not guarantee representation, case acceptance, or financial compensation.
- • California Rule of Professional Conduct 1-400: This is attorney advertising. For California residents: information submitted may be shared with participating attorneys licensed in California. No guarantee of outcome. Free consultation does not create an attorney-client relationship until a signed retainer agreement is executed with a participating law firm.